Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,727.44
+14.660.86%
Number of Gainers:5
Number of Losers:2
Number of Flat:- -
PE:- -
High:1,745.93
Open:1,710.27
Low:1,697.28
Close:1,712.79
Volume:60.92M
Turnover:5.75B
Market Cap:1.80T
Float Cap:1.73T

Loading ...

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

Pfizer Currently up Eight Days Straight, on Pace for Longest Winning Streak Since April 2021

Dow Jones
·
Aug 11

Cloud AI Today - Novo Nordisk Partners With AWS For AI-Driven Drug Discovery

Simply Wall St.
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11

NYSE Most Active Issues

Dow Jones
·
Aug 11

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Press Release: Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 11

MHRA authorizes Eli Lilly’s weight loss pill Foundayo in UK

TIPRANKS
·
Aug 11

Cboe data shows mixed options sentiment in Pfizer with shares up 1.1%

TIPRANKS
·
Aug 11

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

TradingKey
·
Aug 11

Eli Lilly Rises After UK Regulator Approves Weight-Loss Drug

Reuters
·
Aug 11

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 11

Novo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion

TIPRANKS
·
Aug 10

Novo Nordisk reports vesting of 100th Anniversary restricted shares to board and EVP

TIPRANKS
·
Aug 10

Altimmune Inc Expected to Post a Loss of 14 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Novo Nordisk, Amazon Web Services Collaborate to Advance Drug Discovery for Chronic Diseases

MT Newswires Live
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Vanda (VNDA) and AbCellera Biologics (ABCL)

TIPRANKS
·
Aug 10